SCHEMBL1314564

SCHEMBL1314564

CC(C)C(c1ccccc1)(C(C)C)C(C)CCO[SiH3]

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.34
CYP2C19 P33261 2/20 0.34
ALDH1A1 P00352 1/20 0.34
HSD17B10 Q99714 1/20 0.34
RIPK1 Q13546 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.32
MAPK1 P28482 1/20 0.31
CHRM3 P20309 2/20 0.31
CHRM2 P08172 1/20 0.31
CHRM1 P11229 1/20 0.31
KIF11 P52732 1/20 0.31
HIF1A Q16665 1/20 0.31
KCNH2 Q12809 2/20 0.30
MEN1 O00255 1/20 0.30
TTR P02766 1/20 0.30
KMT2A Q03164 1/20 0.30
MRGPRX2 Q96LB1 1/20 0.30
HRH2 P25021 1/20 0.30
HTR2A P28223 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1313465 0.83 CYP2D6 (0.34) CYP2D6CYP2C19ALDH1A1HSD17B10RIPK1
SCHEMBL3079554 0.72 CYP2D6 (0.46) CYP2D6CYP2C19ALDH1A1HSD17B10RIPK1
SCHEMBL702618 0.71 RIPK1 (0.35) CYP2D6CYP2C19ALDH1A1HSD17B10RIPK1
SCHEMBL1315771 0.70 GRIN1 (0.38) CYP2D6CYP2C19ALDH1A1HSD17B10CHRM3
SCHEMBL1314976 0.70 KCNH2 (0.33) CYP2D6CYP2C19ALDH1A1HSD17B10CHRM3
SCHEMBL706262 0.69 RIPK1 (0.33) CYP2D6CYP2C19ALDH1A1HSD17B10RIPK1
SCHEMBL837630 0.68 RIPK1 (0.52) RIPK1
SCHEMBL1317834 0.67 GRIN1 (0.37) CYP2D6CYP2C19ALDH1A1HSD17B10RIPK1
SCHEMBL704126 0.67 CYP2D6 (0.36) CYP2D6CYP2C19ALDH1A1HSD17B10RIPK1
SCHEMBL1314494 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8163950-B2 Processes for the production of tri-organo-monoalkoxysilanes and process for the production of tri-organo-monochlorosilanes SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-04-24 US disclosed
US-20110275849-A1 PROCESSES FOR THE PRODUCTION OF TRI-ORGANO-MONOALKOXYSILANES AND PROCESS FOR THE PRODUCTION OF TRI-ORGANO-MONOCHLOROSILANES BANNOU TADASHI 2011-11-10 US disclosed
US-8008521-B2 Processes for the production of tri-organo-monoalkoxysilanes and process for the production of tri-organo-monochlorosilanes HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) 2011-08-30 US disclosed
US-20090082585-A1 PROCESSES FOR THE PRODUCTION OF TRI-ORGANO-MONOALKOXYSILANES AND PROCESS FOR THE PRODUCTION OF TRI-ORGANO-MONOCHLOROSILANES BANNOU TADASHI 2009-03-26 US disclosed
US-7459577-B2 Reacting a chlorosilane with grignard reagent SHIN-ETSU CHEMICAL CO., LTD. (JP) 2008-12-02 US disclosed
US-20050070730-A1 Production processes for triorganomonoalkoxysilanes and triorganomonochlorosilanes SHIN-ETSU CHEMICAL CO., LTD. (JP) 2005-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275849-A1 PROCESSES FOR THE PRODUCTION OF TRI-ORGANO-MONOALKOXYSILANES AND PROCESS FOR THE PRODUCTION OF TRI-ORGANO-MONOCHLOROSILANES MLX, HAX1, RPS4X CYP2D6 2984/4885CYP2C19 1865/4885ALDH1A1 2163/4885
US-20090082585-A1 PROCESSES FOR THE PRODUCTION OF TRI-ORGANO-MONOALKOXYSILANES AND PROCESS FOR THE PRODUCTION OF TRI-ORGANO-MONOCHLOROSILANES MLX, HAX1, RPS4X CYP2D6 2984/4885CYP2C19 1865/4885ALDH1A1 2163/4885
US-20050070730-A1 Production processes for triorganomonoalkoxysilanes and triorganomonochlorosilanes MLX, HAX1, GRIA3 CYP2D6 3008/4885CYP2C19 2201/4885ALDH1A1 2839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.